3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
7
Sarcoma
6
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
3
Liposarcoma, Myxoid
3
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Sarcoma, Synovial
2
Neurofibrosarcoma
2
Melanoma
2
Liposarcoma
2
Leiomyosarcoma
2
Histiocytoma, Malignant Fibrous
2
Fibrosarcoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Advanced Refractory Solid Tumors
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thymoma
1
Small Cell Lung Cancer Limited Stage
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Pancreatic Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Myosarcoma
1
Lymphatic Metastasis
1
Lymphangiosarcoma
1
Locally Recurrent Rectal Cancer
1
Interventions
Radiotherapy, Intensity-Modulated
3
Cisplatin
2
encorafenib
1
binimetinib
1
alovudine
1
X-Rays
1
Specimen Handling
1
Radiotherapy
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Platinum
1
Nivolumab
1
Metastasectomy
1
Magnetic Resonance Spectroscopy
1
Leuprolide
1
Ipilimumab
1
Goserelin
1
Drug Therapy
1
Docetaxel
1
Axitinib
1
Androgen Antagonists
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphatic Metastasis
×
Radiation Dose Hypofractionation
×
Clear all
NCT03796767
2026-01-28
SOAR
University of Utah
Phase 2
Active not recruiting
20 enrolled
26 charts